Using Machine Learning to Predict Advanced-Stage Progression of Intermediate-Stage Hepatocellular Carcinoma after Transarterial Chemoembolization

The CatBoost machine learning model accurately predicted advanced-stage progression of intermediate-stage hepatocellular carcinoma after transarterial chemoembolization (TACE) and identified patients who benefited from post-TACE systemic therapy.